Standing in front of refrigerators filled with boxes of insulin in a pharmacy in Southern California, Gov. Gavin Newsom revealed that the state has signed a contract with Civica Rx to produce its own insulin and sell it at an affordable price.
LEHI, Utah--(BUSINESS WIRE)--Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work. Once approved, Civica’s biosimilar versions of the most commonly used short-and long-acting insulins will be available to Californians and nationwide at significantly lower prices than insulins currently on the market. The availability of these insulins will benefit Californians with diabetes who have been forced to choose between life sustaining medicines and living expenses.
Civica, Inc. has selected Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for the company’s affordable insulins.
Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Starting today, global healthcare company AmerisourceBergen will serve as Civica, Inc.’s (Civica) exclusive distribution partner and provide supply chain support for Civica’s products and a best-in-class customer experience for Civica members. Through its distribution network, AmerisourceBergen will work to ensure that Civica’s crucial products reach its members across the country efficiently, reliably, and securely. This partnership, which is being rolled out to Civica members in phases throughout the first half of 2023, aims to accelerate both organization’s mutual efforts to ensure the stability of supply of essential generic medicines nationwide.
Lacerations aren’t typically the sort of side effect one associates with a faulty drug, but in Exela Pharma Sciences’ case, the threat has prompted a mass recall of an injectable used to treat a kidney disease complication.
Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection
The draft is intended to help companies develop and implement risk management plans (RMPs) to assist with any shortages of drugs or biologics. The guidance recommends a framework and factors for stakeholders to develop RMPs for their establishments, API manufacturers and others.
SALT LAKE CITY--(BUSINESS WIRE)--Nomi Health, the direct healthcare company delivering easy access to low-cost care across the U.S., has contributed $5 million to an initiative by nonprofit generic pharmaceutical company Civica, Inc. (Civica, Civica Rx) to help accelerate the production of low-cost insulin for people living with diabetes in the U.S.
WILMINGTON, N.C., May 3, 2022 /PRNewswire/ -- Alcami, a leading United States-based contract?development and manufacturing organization (CDMO), announced today that it is partnering with Civica Inc. (Civica Rx), a nonprofit pharmaceutical company focused on ensuring quality generic medicines are accessible and affordable to everyone. With the execution of this agreement, Alcami will provide analytical support for products to be manufactured at Civica's 140,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.